Clinical Trial Update: Maintenance Therapy With Anti-PD-1 Antibody for Patients With NK/T-cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating maintenance therapy with an anti-PD-1 antibody in extranodal NK/T-cell lymphoma, nasal type; status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Nk T-cell Lymphoma Nasal Type

Drugs mentioned

• Anti-PD-1 antibody

Snippet

Sponsor: Beijing Tongren Hospital | Conditions: Extranodal NK/T-cell Lymphoma, Nasal Type | Phase 2 | Status: UNKNOWN